General Information of Drug (ID: DMFT3J2)

Drug Name
Decyl-phosphonic acid
Synonyms
Decylphosphonic acid; 6874-60-8; Decanephosphonic acid; Phosphonic acid, decyl-; 1-Decanephosphonic acid; n-Decylphosphonic acid; 1-DECYLPHOSPHONIC ACID; Phosphonic acid, P-decyl-; EINECS 229-975-2; NSC 407850; BRN 1771572; AI3-23065; CHEMBL188083; DZQISOJKASMITI-UHFFFAOYSA-N; C10H23O3P; DecylphosphonicAcid; 1-decanephosphonicacid; n-Decanephosphonic acid; ACMC-1CUHV; Phosphonic acid,P-decyl-; Decylphosphonic acid, 97%; AC1Q6RQ2; 10; 4-04-00-03564 (Beilstein Handbook Reference); SCHEMBL110008
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
#Ro5 Violations (Lipinski): 0 Molecular Weight (mw) 222.26
Logarithm of the Partition Coefficient (xlogp) 2.9
Rotatable Bond Count (rotbonds) 9
Hydrogen Bond Donor Count (hbonddonor) 2
Hydrogen Bond Acceptor Count (hbondacc) 3
Chemical Identifiers
Formula
C10H23O3P
IUPAC Name
decylphosphonic acid
Canonical SMILES
CCCCCCCCCCP(=O)(O)O
InChI
InChI=1S/C10H23O3P/c1-2-3-4-5-6-7-8-9-10-14(11,12)13/h2-10H2,1H3,(H2,11,12,13)
InChIKey
DZQISOJKASMITI-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
81309
CAS Number
6874-60-8
TTD ID
D06YTN

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Lysophosphatidic acid receptor 1 (LPAR1) TTQ6S1K LPAR1_HUMAN Inhibitor [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

Molecular Expression Atlas of This Drug

The Studied Disease Discovery agent
ICD Disease Classification N.A.
Molecule Name Molecule Type Gene Name p-value Fold-Change Z-score
Lysophosphatidic acid receptor 1 (LPAR1) DTT LPAR1 6.48E-01 -0.04 -0.24
Molecular Expression Atlas (MEA) Jump to Detail Molecular Expression Atlas of This Drug

References

1 Synthesis, structure-activity relationships, and biological evaluation of fatty alcohol phosphates as lysophosphatidic acid receptor ligands, activ... J Med Chem. 2005 Jul 28;48(15):4919-30.